Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2025-12-24 @ 10:04 PM
NCT ID:
NCT02220335
Eligibility Criteria:
Inclusion Criteria:
* Age\>18yr
* "Reactive"Pulmonary Hypertension in Left Heart Failure: mPAPā„25 mmHg, PCWP\>15 mmHg and pulmonary vascular resistance (PVR) \[The PVR =(mPAP-PCWP)/ carbon monoxide\]\>3.0 woods unit
* Voluntary acceptance of all follow-up assessment of program requirements.
Exclusion Criteria:
* WHO group I, III, IV, V pulmonary artery hypertension
* Severe Renal dysfunction (Ccr\<30 ml/min)
* Blood platelet count\<100,000/L
* Expected life span\<12-month
* In pregnancy
* Systematical inflammation
* Malignant cancer(s)
* Tricuspid valve stenosis, Supra-pulmonary valve stenosis
* Allergic to studied drugs or metal materials
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02220335
Study Brief:
Protocol Section:
NCT02220335